Comparative study on efficacy of empagliflozin versus sitagliptin, as an add-on therapy to metformin in type 2 diabetic patients

• المؤلفون الرئيسيون: Harsh Salankar (مؤلف), Sonali Rode (مؤلف), C Arjun (مؤلف), Rajeeta Joseph (مؤلف), Gourav B Deshmane (مؤلف), Radhika P Vijayan (مؤلف)
• التنسيق: كتاب
• منشور في: Wolters Kluwer Medknow Publications, 2024-01-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Introduction: More than 28.7 million individuals throughout the globe suffer from diabetes mellitus, with an estimated 11 percent of the population living with the condition in India. Changes in lifestyle and a variety of treatment plans are used in management. Metformin is a key drug for glycemic c...